Cite
HARVARD Citation
Blauvelt, A. et al. (2018). Safety of tildrakizumab for moderate‐to‐severe plaque psoriasis: pooled analysis of three randomized controlled trials. British journal of dermatology. pp. 615-622. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Blauvelt, A. et al. (2018). Safety of tildrakizumab for moderate‐to‐severe plaque psoriasis: pooled analysis of three randomized controlled trials. British journal of dermatology. pp. 615-622. [Online].